Over the last 10 years, the OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE recorded 11,246 award actions totaling $41.42 billion in obligations, with an average action value of $3.68 million. Spending is concentrated in biotechnology research, pharmaceutical manufacturing, biological product manufacturing, and medical supply channels.
Federal Agency
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Federal Contract Obligations (Last 10 Years)
Federal procurement profile for the OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (Agency ID 7505) covering obligations, award activity, vendors, and NAICS trends over the last 10 years.
Annual trend figures shown for 2021-2025 and vendor and NAICS totals reflect the supplied analysis window and source rows.
Agency ID
7505
Total Obligated
41.42 billion
41,424,590,254.01
Award Actions
11,246
Average Action Value
3,683,495.48
About OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE federal contract activity
Over the last 10 years, the Office of Assistant Secretary for Preparedness and Response recorded $41.42 billion in obligations across 11,246 awards, for an average award value of $3.68 million. The portfolio reflects a large, transaction-heavy procurement base with spending concentrated in health preparedness, biomedical development, and medical supply-related activities.
Vendor concentration and leading contractors
Obligations are led by ADVANCED TECHNOLOGY INTERNATIONAL at $4.03 billion across 72 awards, followed by EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. at $2.37 billion across 77 awards and MODERNATX, INC. at $1.75 billion across 24 awards. The remaining top vendors, BAVARIAN NORDIC A/S and REGENERON PHARMACEUTICALS, INC., also indicate a procurement profile centered on advanced life sciences and vaccine or therapeutic development.
Industry profile based on NAICS activity
The largest NAICS category is 541714, Research and Development in Biotechnology (except Nanobiotechnology), with $10.62 billion across 1,625 awards, followed by 325412 Pharmaceutical Preparation Manufacturing at $5.48 billion across 793 awards. Additional major activity appears in 541711, 325414, and 423450, confirming sustained emphasis on biotechnology R&D, biological manufacturing, and medical supply distribution.
Annual contract trend over the analysis window
Annual obligations were elevated in 2023 at $8.68 billion across 1,246 awards, then declined to $5.25 billion in 2024 and $1.72 billion in 2025 to date. Earlier years in the window were also substantial, including $3.99 billion in 2022 and $4.46 billion in 2021, indicating a procurement pattern that expanded sharply before easing in the most recent periods.
How to interpret this page
This summary uses FPDS Query award data for the Office of Assistant Secretary for Preparedness and Response, Agency ID 7505, limited to the last 10 years. Obligated dollars, award counts, average award value, vendor rankings, NAICS concentrations, and annual trends are based on the provided totals and reflect obligations recorded in FPDS, not outlays or expenditures.
Top Vendors
SELECT
vendor_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__vendor__vendorHeader__vendorName AS vendor_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__purchaserInformation__contractingOfficeAgencyID = '7505'
AND content__award__vendor__vendorHeader__vendorName IS NOT NULL
AND content__award__vendor__vendorHeader__vendorName != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY vendor_name
)
ORDER BY total_obligated DESC
LIMIT 10| Vendor | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| ADVANCED TECHNOLOGY INTERNATIONAL | 4,028,825,157.46 | 4.03 billion | 72 |
| EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | 2,370,780,142.57 | 2.37 billion | 77 |
| MODERNATX, INC. | 1,754,345,480.45 | 1.75 billion | 24 |
| BAVARIAN NORDIC A/S | 1,266,884,128.00 | 1.27 billion | 24 |
| REGENERON PHARMACEUTICALS, INC. | 981,606,627.57 | 981.61 million | 39 |
| AMGEN USA INC. | 906,653,029.75 | 906.65 million | 17 |
| SEQIRUS, INC. | 836,541,345.34 | 836.54 million | 87 |
| WALGREEN CO. | 821,303,840.00 | 821.30 million | 8 |
| MCKESSON MEDICAL-SURGICAL GOVERNMENT SOLUTIONS LLC | 755,210,966.33 | 755.21 million | 80 |
| SIGA TECHNOLOGIES, INC. | 691,767,710.84 | 691.77 million | 41 |
Insight
Over the last 10 years, the agency obligated $41.42 billion across 11,246 awards, with spending concentrated among a small group of vendors. Advanced Technology International received the most obligations at $4.03 billion, followed by Emergent Product Development Gaithersburg Inc. at $2.37 billion, ModernaTX, Inc. at $1.75 billion, and Bavarian Nordic A/S at $1.27 billion. The remaining top vendors each received less than $1.0 billion, indicating a long tail of obligations beyond the leading suppliers. Award volume is also distributed across multiple vendors, with some high-obligation vendors receiving relatively few awards, suggesting a mix of large-value and recurring procurement activity.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__purchaserInformation__contractingOfficeAgencyID = '7505'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 10,621,561,854.19 | 10.62 billion | 1,625 |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | 5,484,701,210.67 | 5.48 billion | 793 |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | 4,589,802,630.93 | 4.59 billion | 1,360 |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 4,309,580,367.48 | 4.31 billion | 716 |
| 423450 | MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | 2,234,029,614.02 | 2.23 billion | 277 |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | 2,043,420,014.71 | 2.04 billion | 123 |
| 236210 | INDUSTRIAL BUILDING CONSTRUCTION | 1,656,922,956.05 | 1.66 billion | 113 |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | 1,644,651,101.59 | 1.64 billion | 591 |
| 621511 | MEDICAL LABORATORIES | 1,480,579,060.70 | 1.48 billion | 38 |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | 1,469,003,215.27 | 1.47 billion | 201 |
Insight
Over the last 10 years, obligations for the Office of Assistant Secretary for Preparedness and Response are concentrated in biomedical research and medical countermeasure supply chains, with NAICS 541714 alone accounting for $10.62 billion across 1,625 awards. The next largest categories are pharmaceutical preparation manufacturing ($5.48 billion), biotechnology R&D ($4.59 billion), and biological product manufacturing ($4.31 billion), indicating a strong emphasis on research, development, and production of health-related goods and services. Smaller but still material obligations are spread across medical equipment wholesale, medical instrument manufacturing, construction, laboratory services, and in-vitro diagnostic manufacturing, suggesting a secondary mix of acquisition and support activities.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__purchaserInformation__contractingOfficeAgencyID = '7505'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 1,720,219,621.95 | 1.72 billion | 1,050 |
| 2024 | 5,247,091,078.87 | 5.25 billion | 1,497 |
| 2023 | 8,684,759,192.45 | 8.68 billion | 1,246 |
| 2022 | 3,987,484,424.40 | 3.99 billion | 1,241 |
| 2021 | 4,457,991,687.51 | 4.46 billion | 1,112 |
| 2020 | 11,951,408,162.21 | 11.95 billion | 1,495 |
| 2019 | 1,869,287,781.13 | 1.87 billion | 813 |
| 2018 | 1,099,269,904.69 | 1.10 billion | 1,146 |
| 2017 | 1,214,254,742.17 | 1.21 billion | 906 |
| 2016 | 1,192,823,658.63 | 1.19 billion | 740 |
Insight
Over the last 10 years, the agency obligated $41.42 billion across 11,246 awards, with an average award value of $3.68 million. Obligations were concentrated in a few peak years, led by 2020 at $11.95 billion and 2023 at $8.68 billion, while most other years ranged from about $1.10 billion to $5.25 billion. Award counts were also highest in 2024 and 2020 at 1,497 each, indicating periods of elevated procurement activity rather than a steady annual pattern.
Use FPDS Query for deeper analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper market analysis across agencies, vendors, NAICS, and contract trends.
Continue from this last 10 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.